The κ opioid system regulates endothelial cell differentiation and pathfinding in vascular development

Blood

Volumn 118, Issue 3, 2011, Pages 775-785

  Yamamizu, Kohei ^a,b   Furuta, Sadayoshi ^c   Katayama, Shiori ^a,b   Narita, Michiko ^c   Kuzumaki, Naoko ^c   Imai, Satoshi ^c   Nagase, Hiroshi ^d   Suzuki, Tsutomu ^c   Narita, Minoru ^c   Yamashita, Jun K ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c HOSHI UNIVERSITY   (Japan)

^d KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; 8 BROMOADENOSINE 3',5' CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DYNORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; G PROTEIN COUPLED RECEPTOR; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; N6 BENZOYL CYCLIC AMP; NALFURAFINE; RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ARTICLE; BLOOD VESSEL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 79960694566     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-09-306001     Document Type: Article

References (36)

1. Kieffer BL, Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog Neurobiol. 2002;66(5):285-306. (Pubitemid 34518287)
2. Zhu Y, Hsu MS, Pintar JE. Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse. J Neurosci. 1998;18(7):2538-2549. (Pubitemid 28141801)
3. Tripathi A, Khurshid N, Kumar P, et al. Expression of delta- and mu-opioid receptors in the ventricular and subventricular zones of the developing human neocortex. Neurosci Res. 2008;61(3):257-270.
4. Narita M, Kuzumaki N, Miyatake M, et al. Role of delta-opioid receptor function in neurogenesis and neuroprotection. J Neurochem. 2006;97(5):1494-1505. (Pubitemid 43725587)
5. Kim E, Clark AL, Kiss A, et al. Mu- and kappaopioids induce the differentiation of embryonic stem cells to neural progenitors. J Biol Chem. 2006;281(44):33749-33760. (Pubitemid 46036753)
6. Hahn JW, Jagwani S, Kim E, et al. Mu and kappa opioids modulate mouse embryonic stem cell-derived neural progenitor differentiation via MAP kinases. J Neurochem. 2010;112(6):1431-1441.
7. Sheng WS, Hu S, Herr G, et al. Human neural precursor cells express functional kappa-opioid receptors. J Pharmacol Exp Ther. 2007;322(3):957-963. (Pubitemid 47295810)
8. Zagon IS, Wu Y, McLaughlin PJ. Opioid growth factor-dependent DNA synthesis in the neonatal rat aorta. Am J Physiol. 1996;270(1 Pt 2):R22-R32.
9. Wu Y, McLaughlin PJ, Zagon IS. Ontogeny of the opioid growth factor, [Met5]-enkephalin, preproenkephalin gene expression, and the zeta opioid receptor in the developing and adult aorta of rat. Dev Dyn. 1998;211(4):327-337. (Pubitemid 28175897)
10. Blebea J, Mazo JE, Kihara TK, et al. Opioid growth factor modulates angiogenesis. J Vasc Surg. 2000;32(2):364-373. (Pubitemid 30644951)
11. Molina PE. Stress-specific opioid modulation of haemodynamic counter-regulation. Clin Exp Pharmacol Physiol. 2002;29(3):248-253. (Pubitemid 34233985)
12. Qu ZX, Xu J, Hogan EL, et al. Effect of U-50488h, a selective opioid kappa receptor agonist, on vascular injury after spinal cord trauma. Brain Res. 1993;626(1-2):45-49. (Pubitemid 23306810)
13. Soker S, Takashima S, Miao HQ, et al. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 1998;92(6):735-745. (Pubitemid 28155313)
14. Cimato T, Beers J, Ding S, et al. Neuropilin-1 identifies endothelial precursors in human and murine embryonic stem cells before CD34 expression. Circulation. 2009;119(16):2170-2178.
15. Kitsukawa T, Shimono A, Kawakami A, et al. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development. 1995;121(12):4309-4318. (Pubitemid 26007578)
16. Kawakami A, Kitsukawa T, Takagi S, et al. Developmentally regulated expression of a cell surface protein, neuropilin, in the mouse nervous system. J Neurobiol. 1996;29(1):1-17. (Pubitemid 26021768)
17. Gitler AD, Lu MM, Epstein JA. PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development. Dev Cell. 2004;7(1):107-116. (Pubitemid 39172692)
18. Torres-Vázquez J, Gitler AD, Fraser SD, et al. Semaphorin-plexin signaling guides patterning of the developing vasculature. Dev Cell. 2004;7(1):117-123. (Pubitemid 39172693)
19. Gu C, Yoshida Y, Livet J, et al. Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science. 2005;307(5707):265-268. (Pubitemid 40116243)
20. Lamont RE, Lamont EJ, Childs SJ. Antagonistic interactions among Plexins regulate the timing of intersegmental vessel formation. Dev Biol. 2009;331(2):199-209.
21. Carmeliet P, Tessier-Lavigne M. Common mechanisms of nerve and blood vessel wiring. Nature. 2005;436(7048):193-200. (Pubitemid 41021263)
22. Yamashita J, Itoh H, Hirashima M, et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature. 2000;408(6808):92-96.
23. Yamamizu K, Kawasaki K, Katayama S, et al. Enhancement of vascular progenitor potential by protein kinase A through dual induction of Flk-1 and Neuropilin-1. Blood. 2009;114(17):3707-3716.
24. + cells at a diverging point of endothelial and hemopoietic lineages. Development. 1998;125(9):1747-1757.
25. Yamamizu K, Matsunaga T, Uosaki H, et al. Convergence of Notch and beta-catenin signaling induces arterial fate in vascular progenitors. J Cell Biol. 2010;189(2):325-338.
26. Yurugi-Kobayashi T, Itoh H, Schroeder T, et al. Adrenomedullin/cyclic AMP pathway induces Notch activation and differentiation of arterial endothelial cells from vascular progenitors. Arterioscler Thromb Vasc Biol. 2006;26(9):1977-1984. (Pubitemid 44253777)
27. Sharifi N, Diehl N, Yaswen L, et al. Generation of dynorphin knockout mice. Brain Res Mol Brain Res. 2001;86(1-2):70-75. (Pubitemid 32124760)
28. Taketa Y, Niikura K, Kobayashi, Y et al. Direct evidence for the ongoing brain activation by enhanced dynorphinergic system in the spinal cord under inflammatory noxious stimuli. Anesthesiology. 2010;112(2):418-431.
29. Simonin F, Valverde O, Smadja C, et al. Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal. EMBO J. 1998;17(4):886-897. (Pubitemid 28077643)
30. Sato Y, Watanabe T, Saito D, et al. Notch mediates the segmental specification of angioblasts in somites and their directed migration toward the dorsal aorta in avian embryos. Dev Cell. 2008;14(6):890-901. (Pubitemid 351757203)
31. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86(3):353-364. (Pubitemid 26272076)
32. Watanabe K, Hasegawa Y, Yamashita H, et al. Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis. J Clin Invest. 2004;114(7):898-907. (Pubitemid 39578717)
33. Chauvet S, Cohen S, Yoshida Y, et al. Gating of Sema3E/PlexinD1 signaling by neuropilin-1 switches axonal repulsion to attraction during brain development. Neuron. 2007;56(5):807-822. (Pubitemid 350181350)
34. Koodie L, Ramakrishnan S, Roy S. Morphine suppresses tumor angiogenesis through a HIF-1alpha/p38MAPK pathway. Am J Pathol. 2010; 177(2):984-997.
35. Singleton PA, Lingen MW, Fekete MJ, Garcia JG, Moss J. Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation. Microvasc Res. 2006;72(1-2):3-11. (Pubitemid 44118390)
36. Singleton PA, Mambetsariev N, Lennon FE, et al. Methylnaltrexone potentiates the antiangiogenic effects of mTOR inhibitors. J Angiogenes Res. 2010;2(1):5.